The Transplant Pharmacy, LLC

The Transplant Pharmacy, LLC was paid $690K by Medicaid between Jan 2018 and Dec 2024, across 8 billing codes. Its largest line is J7518, Mycophenolic acid, oral, 180 mg — 33% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	5,565	$38K
2019	9,361	$88K
2020	12,059	$147K
2021	15,885	$159K
2022	13,900	$128K
2023	9,883	$99K
2024incomplete	5,587	$31K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
J7518	Mycophenolic acid, oral, 180 mg	33%	5,718	5,176	$229K
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	31%	1,184	1,033	$216K
J7507	Tacrolimus, immediate release, oral, 1 mg	20%	12,318	10,670	$139K
J7517	Mycophenolate mofetil, oral, 250 mg	6.8%	6,531	5,660	$47K
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	3.2%	24,968	12,116	$22K
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	3.0%	11,987	11,141	$21K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	2.3%	9,510	8,641	$16K
Q0510	Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant	<1%	24	23	$40.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGULLEY, JAMES (VICE PRESIDENT)